How exactly do you come to a $6 billion value for a company with no FDA approved drug? You're saying that the collective mechanism that is the "market" is undervaluing ARIAD by some $30/share right now?
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.